This is what analysts have to say about Braskem SA (ADR) (NYSE:BAK) after last week.

July 18, 2017 - By Marie Mckinney

 This is what analysts have to say about Braskem SA (ADR) (NYSE:BAK) after last week.

Braskem SA (ADR) (NYSE:BAK) Ratings Coverage

Among 4 analysts covering Braskem SA (NYSE:BAK), 4 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Braskem SA had 5 analyst reports since September 21, 2015 according to SRatingsIntel. The firm has “Buy” rating by Bank of America given on Tuesday, May 24. The firm has “Overweight” rating by JP Morgan given on Monday, December 5. The stock of Braskem SA (ADR) (NYSE:BAK) earned “Buy” rating by HSBC on Tuesday, October 11. Below is a list of Braskem SA (ADR) (NYSE:BAK) latest ratings and price target changes.

The stock increased 5.20% or $1.18 on July 17, reaching $23.86. About shares traded. Braskem SA (ADR) (NYSE:BAK) has risen 73.46% since July 18, 2016 and is uptrending. It has outperformed by 56.76% the S&P500.

Braskem S.A. produces thermoplastic resins. The company has market cap of $9.00 billion. The Company’s divisions are Basic petrochemicals, Polyolefins, Vinyls, the United States and Europe, and Chemical distribution. It has a 56.4 P/E ratio. It is also engaged in the import and export of chemicals, petrochemicals and fuels, the production, supply and sale of utilities such as steam, water, compressed air, industrial gases, the provision of industrial services, and the production, supply and sale of electric energy.

More recent Braskem SA (ADR) (NYSE:BAK) news were published by: Marketwatch.com which released: “23.86” on December 22, 2009. Also Benzinga.com published the news titled: “Mid-Afternoon Market Update: Peregrine Pharma Drops After Q4 Results; Quidel …” on July 17, 2017. Benzinga.com‘s news article titled: “Mid-Day Market Update: Sevcon Surges Following Acquisition News …” with publication date: July 17, 2017 was also an interesting one.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.